Grantable
New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC) Grant · THE PFIZER FOUNDATION INC
$75,000–$250,000
New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC) Grant Status: ACTIVE Funder: Pfizer, Inc. Amount: US $75,000 - US $250,000 Last Updated: September 08, 2025 Summary The grant titled 'New Mechanisms and Em…
Ask me anything about applying to this grant — your fit, eligibility, or how to start your narrative.
One free message · powered by Grantable AI
Welcome to Grantable
Sign in to start building your grant-ready profile
or
We'll send you a one-time verification code. No password needed. By signing in you agree to our Terms of Service and Privacy Policy.